Evidence map›Paper›PMID 42306508›Full record

ArticleIranian journal of microbiology2026

Epidemiology and subtype analysis of respiratory syncytial virus among hospitalized children under five in Isfahan during early 2024.

Forough Tavakoli, Sharareh Moghim, Vahid Salimi, Mohammad Ali Pourmirzaiee

Abstract read
In one paragraph

Article in Iranian journal of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Forough TavakoliDepartment of Bacteriology and Virology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Sharareh MoghimDepartment of Bacteriology and Virology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Vahid SalimiDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Ali PourmirzaieeDepartment of Pediatrics, Research Institute for Primordial Prevention of Non-Communicable Disease, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Respiratory syncytial virus is the most common virus causing acute respiratory infections in children under 5 years old. We aimed to investigate the prevalence and circulating strains of RSV in hospitalized children in Isfahan. Materials and Methods: Between January and May 2024, children under 5 years of age were enrolled in this study. Nasal swabs were collected from 100 children with acute respiratory infections admitted to the referral pediatric ward at Imam Hossein Children's Hospital in Isfahan, Iran. The prevalence of circulating RSV was investigated using the RSV qPCR detection kit. The virus type was identified by RT-PCR using type A- and B-specific primers. Results: A total of 51 (51%) samples tested positive for RSV. Among them, typing was done in 33 specimens, of which 66.6% (22/33 cases) were assigned as subtype B and 33.3% (11/33 cases) as subtype A. Infants under 6 months were most severely affected by RSV (47.1%, 24/51). RSV-positive samples peaked in February (43.1%), followed by January (29.4%). Conclusion: The results of the current study revealed a high prevalence of RSV and co-circulation of subtypes A and B, with subtype B more prevalent among children. This highlights the importance of ongoing surveillance of RSV.

Indexed as

EpidemiologyPrevalenceRespiratory infectionsRespiratory syncytial virus

Identifiers

PMID42306508
PMCPMC13266040

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.